查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
手術部位感染控制市場：現況分析與預測（2023-2030）
市場調查報告書
商品編碼
1346782

手術部位感染控制市場：現況分析與預測（2023-2030）

Surgical Site Infection Control Market: Current Analysis and Forecast (2023-2030)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 156 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

由於全球外科手術數量的增加，預計手術部位感染控制市場將以 4% 左右的速度穩定成長。 全球每年約 3.1 億例大型手術，其中美國約 4,000 至 5,000 萬例，歐洲約 2,000 萬例。 有幾個因素，包括不良的衛生習慣以及缺乏衛生和消毒，是全世界手術部位感染的主要原因。 除此之外，市場上新產品的推出也推動了預測期內的市場成長。 這將導致全球此類案件的增加。 根據美國醫學會雜誌 (JAMA) 發表的事實，大約 0.5% 至 3% 的接受手術的患者會發生手術部位感染。 組織正在採取各種措施來預防這種疾病。 例如，2022 年 11 月，世界衛生組織 (WHO) 更新了預防手術部位感染的全球指南。

根據感染類型，市場分為淺層切口 SSI、深部切口 SSI 和內臟/腔內 SSI。 2022年全球市場中，淺切SSI領域將佔據最大份額。 表淺切口 SSI 通常發生在最近接受過手術的身體部位。 徵象包括切口部位發紅、發熱、腫脹、疼痛、引流等局部徵候。 為了預防表淺切口 SSI，醫院建議在所有類型的手術過程中使用傷口護理敷料、消毒劑和手術巾進行密切觀察 30 天。 根據美國國立衛生研究院 2023 年 6 月的報告，在 COVID-19 大流行前後，淺層切口 SSI 最為突出，佔 50% 的份額。

依手術方式，市場分為剖腹產手術、胃繞道手術、白內障手術、牙科修復等。 由於全球早產率迅速增加，剖腹產手術預計在預測期內將以高複合年增長率成長。 文化信念和醫療保健品質也在剖腹產的流行中發揮重要作用。 根據世界衛生組織 (WHO) 的報告，全球剖腹產人數不斷增加，佔新生兒總數的 21% 以上。 預計到 2030 年，將透過剖腹產進行近 29% 的分娩。

產品分為備皮液、手術磨砂膏、剪刀、手術清潔液、手術手套、手術單、手工再處理液、消毒液、醫用不織布等。 預計在預測期內，手術手套和消毒劑領域將在市場上佔據重要地位。 對微創手術不斷增長的需求也是推動這一領域發展的因素。 醫療器材製造商正忙於推出新的醫療產品來滿足此類產品的需求。 例如，Mediland 將於 2021 年推出先進的手術台和手術燈。

依最終用途，市場分為醫院、門診手術中心等。 2021年，醫院在手術部位感染控制市場中佔有很大份額。 這是因為大多數手術是在醫院進行的，醫院通常採用手術部位感染控制系統。 除此之外，醫院數量的增加也支持了該行業的成長。 例如，根據美國醫院協會的統計，到2022年，美國將有大約6,100家醫院，由非營利組織以及州和地方政府營運的社區醫院組成。

為了更了解手術部位感染控制的市場介紹，將市場分為北美（美國、加拿大等北美地區）、歐洲（德國、英國、法國、西班牙、義大利等）歐洲地區）和亞太地區（根據其他地區（中國、日本、印度、亞太其他地區）和其他地區的全球影響力進行分析。 由於患者數量的增加和國內醫療保健提供者的增加，預計北美將在 2022 年佔上風。 此外，政府的指導方針和措施也在預測期內推動市場成長。 例如，國家健康與護理卓越研究所 (NICE) 於 2020 年 8 月發布了手術部位感染指南：預防和治療。 預計在預測期內，該地區對手術部位感染控制措施的需求將會增加。

目錄

第 1 章市場介紹

  • 市場定義
  • 主要目標
  • 利害關係人
  • 限制

第 2 章研究方法或假設

  • 調查過程
  • 調查方法
  • 受訪者簡介

第 3 章市場總結

第 4 章執行摘要

第 5 章 COVID-19 對手術部位感染控制市場的影響

第 6 章手術部位感染控制市場收入，2020-2028

第 7 章依傳染病類型劃分的市場洞察

  • 淺切口 SSI
  • 深切口SSI
  • 器官或空間 SSI

第 8 章分步市場洞察

  • 剖腹產
  • 胃繞道手術
  • 白內障手術
  • 牙齒修復
  • 其他

第 9 章按產品劃分的市場洞察

  • 備皮液
  • 手術磨砂膏
  • 快船
  • 手術清潔
  • 手術手套
  • 手術單
  • 手動後處理設備解決方案
  • 消毒劑
  • 醫用不織布
  • 其他

第 10 章最終用途市場洞察

  • 醫院
  • 門診手術中心
  • 其他

第 11 章按地區劃分的市場洞察

  • 北美
    • 美國
    • 加拿大
    • 其他北美地區
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區

第 12 章手術部位感染控制的市場動態

  • 市場促進因素
  • 市場挑戰
  • 影響分析

第 13 章手術部位感染控制的市場機會

第 14 章手術部位感染控制市場趨勢

第 15 章需求方與供給方分析

  • 需求方分析
  • 供給面分析

第 16 章價值鏈分析

第 17 章競爭場景

  • 競爭狀況
    • 波特五力分析

第 18 章公司簡介

  • 3M
  • Becton Dickinson, and Company
  • BioMerieux, SA
  • Getinge AB
  • Johnson & Johnson Limited
  • Sotera Health Company
  • Medtronic Private Limited
  • Prescient Surgical
  • GAMA Healthcare Ltd.
  • ANSELL LTD.

第 19 章免責聲明

簡介目錄
Product Code: UMHE212243

Surgical site infections are the kind of infections that originate at the site of invasive surgery. These infections can be superficial, i.e., on the skin or may proliferate to other body organs as well. For the same reason, these infections are one of the major parts of healthcare-associated infections(HCAI). The Centers for Disease Control and Prevention in U.S. has stated tools and guidelines to help patients understand these surgical site infections and take appropriate measures to protect their own health. The basic types of surgical site infections are superficial incisional SSI, deep incisional SSI, and organ or space SSI. Various types of surgeries can cause this situation like caesarean section, gastric bypass, cataract surgery, and dental restoration. There are numerous factors leading to the development of this market, including innovations in standards and infrastructure of the healthcare sector, rising cases of surgical and operating room development worldwide, increase in trends of maintaining hygiene and sanitation. also, surge in government policies for the welfare of public and rise in demand for minimally invasive procedures are driving the growth of the market during the forecast period.

The Surgical Site Infection Control Market is expected to grow at a steady rate of around 4% owing to the increasing surgical procedures globally. An astounding range of 310 million major surgeries are performed each year worldwide; approximately 40 to 50 million in US and nearly 20 million in Europe. Several factors, such as unhygienic practices, lack of sanitation and sterilization are leading causes of surgical site infection globally. Apart from this, the introduction of new products in the market is also driving the market's growth during the forecast period. This leads to an increase in a number of such cases worldwide. Facts stated by The Journal of the American Medical Association (JAMA) convey that surgical site infections Infections occur in nearly 0.5% to 3% of patients going through surgery. Organizations are taking multiple initiatives to help in preventing this ailment. For instance, the World Health Organization has updated its global guidelines for the prevention of surgical site infection in November,2022.

Based on type of infection, the market is segmented into superficial incisional SSI, deep incisional SSI and organ or space SSI. The superficial incisional SSI segment held the maximum share in the global market in 2022. Superficial incisional SSI usually occurs in the body part which has been recently operated. The signs may include localized signs such as redness, heat, swelling at the site of the incision, pain or the drainage of pus. As per hospital advisories, thirty days of strict monitoring is done with the help of wound care dressing, disinfectants, and surgical drapes in all types of surgeries to prevent superficial incisional SSI. According to the reports of the National Institute of Health in June 2023, superficial incisional SSI were most prominent with the share of 50% before as well as after the COVID-19 pandemic.

On the basis of procedure, the market is categorized into cesarean section, gastric bypass, cataract surgery, dental restoration and others. The caesarean section segment is expected to grow with high CAGR during the forecast period due to a surge in the premature deliveries throughout the world. Also cultural believes and healthcare quality could play a pivotal role in promoting the prevalence of C-sections. The World Health Organization reported the continuous rise in caesarean sections globally, there were more than 21% childbirths. It is estimated that nearly 29% of all births in 2030 are expected to take place via cesarean section.

On the basis of product, the market is differentiated into skin preparation solution, surgical scrubs, hair clippers, surgical irrigation, surgical gloves, surgical drapes, manual reprocessors solution, disinfectants, medical nonwovens and others. Surgical- gloves and disinfectants segment were observed to be significant in the market in the forecast period. The rising demand for minimally invasive surgery is also a propelling factor for this segment which is responsible for its prevalence. Medical device companies are engrossed in launching such medical products in demand. For instance, Mediland launches advanced Surgical Table and SurgicalLight in 2021.

Based on the end use, the market is segmented into hospitals, ambulatory surgical centers and others. The hospitals held the significant share in the surgical site infection control market in 2021. This is due to high adoption of surgical site infection control systems in hospitals as most surgeries are performed in hospital settings. Apart from this, the growing number of hospitals is also propelling the segmental growth. For instance, according to the American Hospital Association, there were about 6,100 hospitals in the U.S. in 2022, which comprised of community hospitals run by non-profit organizations as well as state and local governments.

For a better understanding of the market adoption of the surgical site infection control, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is believed to be dominating in 2022 due to the rising number of patients and increasing healthcare providers in the nation. Further, the guidelines and initiatives by government is also driving the market growth during the forecast period. For instance, The National Institute for Health and Care Excellence (NICE) released guidelines regarding surgical site infections: prevention and treatment in August 2020. Over the projection period, this is expected to increase demand for surgical site infection control initiatives in this region.

Some of the major players operating in the market include: 3M; Becton Dickinson, and Company; BioMerieux, SA; Getinge AB; Johnson & Johnson Limited; Sotera Health Company; Medtronic Private Limited; Prescient Surgical; GAMA Healthcare Ltd.; ANSELL LTD.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Surgical Site Infection Control Market
  • 2.2. Research Methodology of the Surgical Site Infection Control Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE SURGICAL SITE INFECTION CONTROL MARKET

6 SURGICAL SITE INFECTION CONTROL MARKET REVENUE (USD BN), 2020-2028F

7 MARKET INSIGHTS BY TYPE OF INFECTION

  • 7.1. Superficial incisional SSI
  • 7.2. Deep incisional SSI
  • 7.3. Organ or space SSI

8 MARKET INSIGHTS BY PROCEDURE

  • 8.1. Caesarean section
  • 8.2. Gastric bypass
  • 8.3. Cataract surgery
  • 8.4. Dental restoration
  • 8.5. Others

9 MARKET INSIGHTS BY PRODUCT

  • 9.1. Skin preparation solution
  • 9.2. Surgical scrubs
  • 9.3. Hair clippers
  • 9.4. Surgical irrigation
  • 9.5. Surgical gloves
  • 9.6. Surgical drapes
  • 9.7. Manual reprocessors solution
  • 9.8. Disinfectants
  • 9.9. Medical nonwovens
  • 9.10. Others

10 MARKET INSIGHTS BY END USE

  • 10.1. Hospitals
  • 10.2. Ambulatory Surgical Centres
  • 10.3. Others

11 MARKET INSIGHTS BY REGION

  • 11.1. North America
    • 11.1.1. U.S.
    • 11.1.2. Canada
    • 11.1.3. Rest of North America
  • 11.2. Europe
    • 11.2.1. Germany
    • 11.2.2. U.K.
    • 11.2.3. France
    • 11.2.4. Italy
    • 11.2.5. Spain
    • 11.2.6. Rest of Europe
  • 11.3. Asia-Pacific
    • 11.3.1. China
    • 11.3.2. Japan
    • 11.3.3. India
    • 11.3.4. Rest of Asia-Pacific
  • 11.4. Rest of World

12 SURGICAL SITE INFECTION CONTROL MARKET DYNAMICS

  • 12.1. Market Drivers
  • 12.2. Market Challenges
  • 12.3. Impact Analysis

13 SURGICAL SITE INFECTION CONTROL MARKET OPPORTUNITIES

14 SURGICAL SITE INFECTION CONTROL MARKET TRENDS

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porters Fiver Forces Analysis

18 COMPANY PROFILED

  • 18.1. 3M
  • 18.2. Becton Dickinson, and Company
  • 18.3. BioMerieux, SA
  • 18.4. Getinge AB
  • 18.5. Johnson & Johnson Limited
  • 18.6. Sotera Health Company
  • 18.7. Medtronic Private Limited
  • 18.8. Prescient Surgical
  • 18.9. GAMA Healthcare Ltd.
  • 18.10. ANSELL LTD.

19 DISCLAIMER